Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
2025 Human Reproductive and Stem Cell Bank Services Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling human reproductive and ... Read More
-
Bioreactors Market by Product Type (Glass, Stainless Steel, Single-use), Scale (5L-20L, 20L-200L, 200L-1500L, Above 1500L), Control Type, Usage, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... Overview Bioreactors are sophisticated devices designed for the controlled cultivation and manipulation of biological systems, particularly cells or microorganisms, to produce various biological products. These reactors provide a controlled environment with parameters such as temperature, ... Read More
-
Single-Use Bioreactors Market Report by Product Type (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Others), Type (Stirred-tank Bioreactors, Wave-induced Bioreactors, Bubble-column Bioreactors, and Others), Cell Type (Mammalian Cell, Bacteria, Yeast, and Others), Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Others), and Region 2025-2033
... The market is propelled by the increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, significant developments in single-use technology, increasing product adoption in contract manufacturing organizations (CMOs), rising usage in cell and ... Read More
-
Cancer Vaccines Market Report by Type, (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-cell Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, and Others), End User (Pediatrics, Adults), and Region 2025-2033
... The increasing cancer incidence, advancements in immunotherapy, government initiatives and funding, growing awareness and education, rapid technological advancements, strategic collaborations and partnerships, and increasing healthcare expenditure are some of the major factors propelling the market. ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and ... Read More
-
Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030
... technologies, along with the rising cancer cases in the world, are factors supporting the growth of the market. Moreover, the availability of funds and grants for cellular biology research and the growing adoption of HCS ... Read More
-
Cell & Gene Therapies in Dermatology Disorders: Therapeutic Analysis
... anal fistula in adult patients, was the first adipose tissue-derived mesenchymal stem cell (ASC) asset to receive approval in the GI market in Japan, 2012. This was followed by Takeda Pharmaceutical’s Alofisel (darvadstrocel), which received ... Read More
-
Japan CAR-T Cell Therapies Market - 2025-2033
... therapy, or Chimeric Antigen Receptor T-cell therapy, is an advanced immunotherapy used primarily in cancer treatment. It involves engineering a patient's T cells, a type of immune cell, by modifying them to express a chimeric ... Read More
-
Global Oncology Therapy Market - 2025-2033
... period of 2025-2033. Oncology therapy refers to the medical treatments and interventions designed to manage and treat cancer. It encompasses a wide range of therapeutic strategies aimed at eliminating or controlling cancer cells, alleviating symptoms, ... Read More
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
... a high CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives ... Read More
-
Cell Harvesting System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... cell processing, the market is poised for impressive growth. Valued at approximately US$7.35 billion in 2025, the market is projected to reach US$17.4 billion by 2032, expanding at a strong CAGR of 13.09% over the ... Read More
-
Cell Therapy in the US - Industry Market Research Report
... over a decade ago, cell therapy developers have been at the forefront of life sciences innovation, with interest and investment pouring into the field. But, the current regulatory environment hasn't kept up with the rapidly ... Read More
-
2025 Global: Induced Pluripotent Stem Cells (Ipscs) Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
2025 Global: Human Mesenchymal Stem Cells (Hmsc) Market - Innovative Markets Forecast (2031) report
... most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the ... Read More
-
Stem Cell Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Stem Cell/Cord Blood Banking Global Market Report 2025
... blood banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Adult Stem Cell Assay Global Market Report 2025
... cell assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the analysis period. ... Read More
-
Viral Inactivation
... CAGR of 11.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$865.8 Million by the end of the ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Stem Cell Banking
... at a CAGR of 7.5% over the analysis period 2024-2030. Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$10.5 Billion ... Read More
-
Human Organoids
... CAGR of 15.4% over the analysis period 2024-2030. Kidney, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Stem Cell Therapy
... at a CAGR of 16.4% over the analysis period 2024-2030. Allogeneic, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$1.0 Billion by the end of the ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... reach US$1.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Regenerative Medicine, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
Research Assistance
